Top Device Companies

Thermo Fisher, Inverness End Diagnostics Distribution Agreement

Thermo Fisher Scientific lost a $200 million distribution agreement when Inverness Medical Innovations decided to end its agreement and market its diagnostics on its own. The contract, which ends next July 1, involved the Inverness Biosite line of diagnostics. Thermo Fisher said termination of the agreement likely was a response to its decision to expand its own line of products, including competing diagnostics. (Click here for more)

“Inverness Spikes Distribution Agreement With Thermo” – MSN Money (11/10/09)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

Inverness To Pay $200 Million For ACON Diagnostics

Inverness Medical Innovations plans to buy the diagnostics business of ACON Laboratories for about $200 million. Inverness expects to close the deal by the end of April, giving the company the rest of ACON’s diagnostics business that Inverness did not already own. Inverness had bought into part of ACON’s non-U.S. rapid diagnostics business in 2006, the part that included Australia, Canada, European Union, Israel, Japan, New Zealand and the United States. The new deal is for ACON’s business in the rest of the world. (Click here for more)

“Inverness To Buy ACON Test Unit For $200 Million” – AP (3/20/09)

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com